Announced
Completed
Financials
Tags
Venture Capital
Private
Acquisition
Completed
Single Bidder
Friendly
Biotechnology
Private Equity
Minority
France
Cross Border
biotech startup
Synopsis
Bpifrance led a $75m Series B round in TreeFrog Therapeutics, a privately held French-based biotech startup, with participation from Leonard Green & Partners, Bristol Myers Squibb and XAnge. The latest funding round will be used to deploy biomimetic C-StemTM technology for clinical-grade manufacturing, grow and advance to the clinic a comprehensive pipeline of cell therapies, and finance the opening of technological hubs in Boston, MA, and Kobe, Japan.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.